Form 8-K - Current report:
SEC Accession No. 0001387131-13-000292
Filing Date
2013-02-06
Accepted
2013-02-06 17:07:46
Documents
3
Period of Report
2013-01-31
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 3.02: Unregistered Sales of Equity Securities
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT txmd-8k_123112.htm 8-K 25367
2 MULTIPLE ADVANCE REVOLVING CREDIT NOTE ex10_0.htm EX-10.0 52954
3 COMMON STOCK PURCHASE WARRANT ex10_1.htm EX-10.1 145356
  Complete submission text file 0001387131-13-000292.txt   225291
Mailing Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487
Business Address 951 BROKEN SOUND PARKWAY NW SUITE 320 BOCA RATON FL 33487 561-961-1911
TherapeuticsMD, Inc. (Filer) CIK: 0000025743 (see all company filings)

EIN.: 870233535 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-16731 | Film No.: 13578663
SIC: 2834 Pharmaceutical Preparations